CN Patent

CN103396409B — 作为akt蛋白激酶抑制剂的嘧啶基环戊烷

Assigned to Genentech Inc · Expires 2015-03-11 · 11y expired

What this patent protects

本发明提供了式I化合物，包括其互变异构体、拆分的对映异构体、非对映异构体、溶剂合物、代谢产物、盐和可药用前药。还提供了使用本发明化合物作为AKT蛋白激酶抑制剂和用于治疗过度增生性疾病如癌症的方法。

USPTO Abstract

本发明提供了式I化合物，包括其互变异构体、拆分的对映异构体、非对映异构体、溶剂合物、代谢产物、盐和可药用前药。还提供了使用本发明化合物作为AKT蛋白激酶抑制剂和用于治疗过度增生性疾病如癌症的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN103396409B
Jurisdiction
CN
Classification
—
Expires
2015-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Genentech Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.